<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-R3OACDH3</identifier><date>2015</date><creator>Ocvirk, Janja</creator><relation>documents/doc/R/URN_NBN_SI_doc-R3OACDH3_001.pdf</relation><relation>documents/doc/R/URN_NBN_SI_doc-R3OACDH3_001.txt</relation><format format_type="extent">23 str., 21 cm</format><format format_type="type">e-knjige</format><identifier identifier_type="COBISSID">2052219</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-R3OACDH3</identifier><language>slv</language><publisher>Onkološki inštitut</publisher><source>knjige</source><rights>InC</rights><subject language_type_id="slv">Adverse effects</subject><subject language_type_id="slv">Drug therapy</subject><subject language_type_id="slv">interferon</subject><subject language_type_id="slv">Interferon alfa-2b</subject><subject language_type_id="slv">melanom</subject><subject language_type_id="slv">Melanoma</subject><subject language_type_id="slv">zdravljenje</subject><title>Obvladovanje neželenih učinkov zdravljenja malignega melanoma z zdravilom interferon alfa 2b</title></Record>